COMMUNIQUÉS West-GlobeNewswire
-
Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference
26/10/2018 - 11:12 -
Amarin Schedules Webcast Discussion of Primary REDUCE-IT™ Trial Results Following Presentation at 2018 Scientific Sessions of American Heart Association
26/10/2018 - 11:00 -
Nomination Committee appointed for the 2019 Annual General Meeting in PledPharma
26/10/2018 - 08:00 -
C-RAD AB – Interim report January-September 2018
26/10/2018 - 08:00 -
Rule 2.9 announcement
26/10/2018 - 08:00 -
C-RAD AB – Interim report January-September 2018
26/10/2018 - 08:00 -
DBV Technologies Announces Initiation of Part B of Phase III Study in Peanut-Allergic Toddlers
26/10/2018 - 07:31 -
DBV Technologies annonce l'initiation du second volet de la phase III de l'essai réalisé sur de jeunes enfants allergiques à l'arachide
26/10/2018 - 07:31 -
Novartis receives approval for Cosentyx® label update in Europe to include dosing flexibility in psoriatic arthritis
26/10/2018 - 07:16 -
FibroGen Presents Results from Two Phase 3 Studies of Roxadustat for the Treatment of Anemia Associated with Chronic Kidney Disease Conducted in China at American Society of Nephrology Kidney Week 2018 Annual Meeting
26/10/2018 - 01:49 -
Bionano Genomics to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
26/10/2018 - 01:25 -
Adherium Announces Q1 Fiscal Year 2019 Investor Conference Call
26/10/2018 - 00:06 -
TOMI Environmental Solutions, Inc. Exhibits SteraMist™ Disinfection Products at the American Association for Laboratory Animal Science (AALAS) Annual Meeting
25/10/2018 - 23:19 -
MannKind Corporation to Hold 2018 Third Quarter Financial Results Conference Call on November 1, 2018
25/10/2018 - 23:00 -
Adaptimmune to Report Third Quarter 2018 Financial Results and Business Update on Tuesday, November 6, 2018
25/10/2018 - 22:30 -
Spring Bank Pharmaceuticals Reports Third Quarter Financial Results
25/10/2018 - 22:30 -
Histogenics Corporation to Report Third Quarter 2018 Financial Results on November 8, 2018
25/10/2018 - 22:15 -
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
25/10/2018 - 22:05 -
HTG Molecular Diagnostics to Announce Third Quarter and Nine Months Ended September 30, 2018 Financial Results and Host Conference Call on Thursday, November 8
25/10/2018 - 22:05
Pages